Potential Role of SGLT‐2 Inhibitors in Improving Allograft Function and Reducing Rejection in Kidney Transplantation

Documenti analoghi

• Persistent Chronic Active T‐Cell‐Mediated Rejection After Kidney Transplantation Is Associated With Poor Allograft Survival
  di: Hiroshi Noguchi, et al.
  Pubblicazione: (2024)
• Safety and Tolerability of SGLT‐2 Inhibitors Following Lung Transplantation
  di: Peter Wilcox, et al.
  Pubblicazione: (2025)
• T‐cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel
  di: Adarsh Barwad, et al.
  Pubblicazione: (2024)
• A Comprehensive Assessment of Plasma CXCL9 and CXCL10 in Improving Clinical Prediction Models for Kidney Allograft Rejection
  di: Alvaro Assis de Souza, et al.
  Pubblicazione: (2025)
• Efficacy of Steroid Pulse to Treat Borderline T‐Cell Mediated Rejection on Protocol Kidney Allograft Biopsy
  di: Georgia Kirn, et al.
  Pubblicazione: (2025)